Sentinel node biopsy and selective lymph node clearance--impact on regional control and survival in breast cancer and melanoma (Q81718534)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15875179%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

title

Sentinel node biopsy and selective lymph node clearance--impact on regional control and survival in breast cancer and melanoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15875179%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

author name string

Omgo E Nieweg

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15875179%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Maartje C van Rijk

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15875179%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Renato A Valdés Olmos

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15875179%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Cornelis A Hoefnagel

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15875179%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

publication date

1 June 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15875179%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

number of pages

4

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15875179%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

volume

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15875179%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15875179%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

page(s)

631-634

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15875179%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00259-005-1801-4

11 January 2020

exact match

0 references

cites work

Omitting axillary lymph node dissection in sentinel node negative breast cancer patients is safe: a long term follow-up analysis.

1 reference

12 December 2020

Sentinel lymphadenectomy for patients with clinical stage I melanoma

1 reference

12 December 2020

Review and evaluation of sentinel node procedures in 250 melanoma patients with a median follow-up of 6 years

1 reference

12 December 2020

The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: a follow-up study of 4008 procedures

1 reference

12 December 2020

Sentinel lymph node biopsy in the management of patients with primary cutaneous melanoma: review of a large single-institutional experience with an emphasis on recurrence

1 reference

12 December 2020

Lymphatic mapping and sentinel lymph node biopsy in breast cancer

1 reference

12 December 2020

Sensitivity of sentinel node biopsy in melanoma

1 reference

12 December 2020

Consequences of axillary recurrence after conservative breast surgery

1 reference

12 December 2020

The sentinel lymph node status is an important factor for predicting clinical outcome in patients with Stage I or II cutaneous melanoma.

1 reference

12 December 2020

Sentinel lymph node biopsy in cutaneous melanoma: the WHO Melanoma Program experience

1 reference

12 December 2020

Technical details of intraoperative lymphatic mapping for early stage melanoma

1 reference

12 December 2020

Clinical outcome of stage I/II melanoma patients after selective sentinel lymph node dissection: long-term follow-up results

1 reference

12 December 2020

Melanoma: questions for the future

1 reference

12 December 2020

Summary of the Second International Sentinel Node Conference

1 reference

12 December 2020

Patients with lymphatic metastasis of cutaneous malignant melanoma benefit from sentinel lymphonodectomy and early excision of their nodal disease

1 reference

12 December 2020

Gamma probe guided biopsy of the sentinel node in malignant melanoma: a multicentre study.

1 reference

12 December 2020

Selective lymphadenectomy in sentinel node-positive patients may increase the risk of local/in-transit recurrence in malignant melanoma

1 reference

12 December 2020

Lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: therapeutic utility and implications of nodal microanatomy and molecular staging for improving the accuracy of detection of nodal micrometastases

1 reference

12 December 2020

Current status of intraoperative lymphatic mapping and sentinel lymphadenectomy for melanoma: is it standard of care?

1 reference

12 December 2020

The sentinel node procedure in patients with melanoma

1 reference

12 December 2020

Lymphatic mapping and selective lymphadenectomy for melanoma: not yet standard therapy.

1 reference

12 December 2020

Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients

1 reference

12 December 2020

Management of cutaneous melanoma

1 reference

12 December 2020

High incidence of in-transit metastases after sentinel node biopsy in patients with melanoma

1 reference

12 December 2020

Regional nodal failure after conservative surgery and radiotherapy for early-stage breast carcinoma

1 reference

12 December 2020

10.1007/S00259-005-1801-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15875179%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

1 reference